Vitamin B12 Deficiency in Thrombotic Thrombocytopenic Purpura-Like Cases.

Q3 Medicine
European journal of case reports in internal medicine Pub Date : 2024-09-13 eCollection Date: 2024-01-01 DOI:10.12890/2024_004714
Inemesit Akpan, Ghida Akhdar, Kaelan Dawson, Amanda Hathaway
{"title":"Vitamin B12 Deficiency in Thrombotic Thrombocytopenic Purpura-Like Cases.","authors":"Inemesit Akpan, Ghida Akhdar, Kaelan Dawson, Amanda Hathaway","doi":"10.12890/2024_004714","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Thrombotic microangiopathies (TMA) are characterized by a triad of microangiopathic hemolytic anemia, thrombocytopenia, and organ damage which occur in the setting of endothelial damage and platelet activation. Vitamin B12 (cobalamin) deficiency could lead to a picture that resembles TMA, termed metabolic mediated TMA (MM-TMA).</p><p><strong>Case presentation: </strong>A 60-year-old female was brought to the hospital after she was found unresponsive. On presentation, she was pale, lethargic, tachycardic, and febrile. Laboratory investigations revealed normocytic anemia, thrombocytopenia, and elevated bilirubin. Blood smear revealed schistocytes and tear drop cells. Given the presence of hemolytic anemia, thrombocytopenia, acute renal failure, and altered mental status, a presumptive diagnosis of thrombotic thrombocytopenic purpura (TTP) was made with a PLASMIC score of 7 indicating high risk. She received plasma exchange, caplacizumab, and intravenous methylprednisolone. Given the patient's low level of vitamin B12, she was initiated on intramuscular cyanocobalamin 1000 μg daily. The encephalopathy resolved and renal function improved. On day 6, <i>ADAMTS13</i> activity was normal ruling out the diagnosis of TTP. Accordingly, plasmapheresis, steroids, and caplacizumab were discontinued. With continued aggressive B12 replacement, hemolysis resolved indicating severe vitamin B12 deficiency was the likely culprit of this patient's microangiopathic hemolytic anemia.</p><p><strong>Conclusion: </strong>This case serves to highlight the variable presentation of vitamin B12 deficiency. Severe vitamin B12 deficiency can even mimic TTP. If patients have markers of hemolysis, a low vitamin B12 level, and low reticulocyte count we should consider vitamin B12 deficiency as a likely cause of microangiopathic hemolytic anemia as early detection allows for early initiation of appropriate management.</p><p><strong>Learning points: </strong>Vitamin B12 deficiency can be a cause of thrombotic microangiopathy.</p>","PeriodicalId":11908,"journal":{"name":"European journal of case reports in internal medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11451856/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of case reports in internal medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12890/2024_004714","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Thrombotic microangiopathies (TMA) are characterized by a triad of microangiopathic hemolytic anemia, thrombocytopenia, and organ damage which occur in the setting of endothelial damage and platelet activation. Vitamin B12 (cobalamin) deficiency could lead to a picture that resembles TMA, termed metabolic mediated TMA (MM-TMA).

Case presentation: A 60-year-old female was brought to the hospital after she was found unresponsive. On presentation, she was pale, lethargic, tachycardic, and febrile. Laboratory investigations revealed normocytic anemia, thrombocytopenia, and elevated bilirubin. Blood smear revealed schistocytes and tear drop cells. Given the presence of hemolytic anemia, thrombocytopenia, acute renal failure, and altered mental status, a presumptive diagnosis of thrombotic thrombocytopenic purpura (TTP) was made with a PLASMIC score of 7 indicating high risk. She received plasma exchange, caplacizumab, and intravenous methylprednisolone. Given the patient's low level of vitamin B12, she was initiated on intramuscular cyanocobalamin 1000 μg daily. The encephalopathy resolved and renal function improved. On day 6, ADAMTS13 activity was normal ruling out the diagnosis of TTP. Accordingly, plasmapheresis, steroids, and caplacizumab were discontinued. With continued aggressive B12 replacement, hemolysis resolved indicating severe vitamin B12 deficiency was the likely culprit of this patient's microangiopathic hemolytic anemia.

Conclusion: This case serves to highlight the variable presentation of vitamin B12 deficiency. Severe vitamin B12 deficiency can even mimic TTP. If patients have markers of hemolysis, a low vitamin B12 level, and low reticulocyte count we should consider vitamin B12 deficiency as a likely cause of microangiopathic hemolytic anemia as early detection allows for early initiation of appropriate management.

Learning points: Vitamin B12 deficiency can be a cause of thrombotic microangiopathy.

血栓性血小板减少性紫癜样病例中的维生素 B12 缺乏症
背景:血栓性微血管病(TMA)以微血管病性溶血性贫血、血小板减少和器官损伤三联症为特征,发生于内皮损伤和血小板活化的环境中。维生素 B12(钴胺素)缺乏可导致与 TMA 相似的症状,即代谢介导的 TMA(MM-TMA):病例介绍:一名 60 岁的女性在被发现无反应后被送往医院。就诊时,她面色苍白、嗜睡、心动过速、发热。实验室检查发现她患有正常细胞性贫血、血小板减少和胆红素升高。血涂片显示有裂殖细胞和泪滴细胞。鉴于存在溶血性贫血、血小板减少、急性肾功能衰竭和精神状态改变,推测诊断为血栓性血小板减少性紫癜(TTP),PLASMIC评分为7分,表明风险很高。她接受了血浆置换、卡普珠单抗和甲基强的松龙静脉注射。鉴于患者的维生素 B12 含量较低,她开始每天肌肉注射氰钴胺 1000 μg。脑病缓解,肾功能也有所改善。第 6 天,ADAMTS13 活性正常,排除了 TTP 的诊断。因此,他停用了血浆置换术、类固醇和卡普拉珠单抗。继续积极补充维生素B12后,溶血症状缓解,这表明严重的维生素B12缺乏症可能是导致该患者微血管病性溶血性贫血的罪魁祸首:本病例凸显了维生素 B12 缺乏症的多变表现。严重的维生素 B12 缺乏症甚至可以模拟 TTP。如果患者有溶血标记物、低维生素 B12 水平和低网织红细胞计数,我们应将维生素 B12 缺乏症视为微血管病性溶血性贫血的可能病因,因为及早发现可以及早开始适当的治疗:维生素 B12 缺乏可导致血栓性微血管病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.10
自引率
0.00%
发文量
166
审稿时长
8 weeks
期刊介绍: The European Journal of Case Reports in Internal Medicine is an official journal of the European Federation of Internal Medicine (EFIM), representing 35 national societies from 33 European countries. The Journal''s mission is to promote the best medical practice and innovation in the field of acute and general medicine. It also provides a forum for internal medicine doctors where they can share new approaches with the aim of improving diagnostic and clinical skills in this field. EJCRIM welcomes high-quality case reports describing unusual or complex cases that an internist may encounter in everyday practice. The cases should either demonstrate the appropriateness of a diagnostic/therapeutic approach, describe a new procedure or maneuver, or show unusual manifestations of a disease or unexpected reactions. The Journal only accepts and publishes those case reports whose learning points provide new insight and/or contribute to advancing medical knowledge both in terms of diagnostics and therapeutic approaches. Case reports of medical errors, therefore, are also welcome as long as they provide innovative measures on how to prevent them in the current practice (Instructive Errors). The Journal may also consider brief and reasoned reports on issues relevant to the practice of Internal Medicine, as well as Abstracts submitted to the scientific meetings of acknowledged medical societies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信